Summit Therapeutics Inc. Amount Presented In Other Comprehensive Income Realised At Derecognition
Summit Therapeutics Inc. (SMMT) reported Amount Presented In Other Comprehensive Income Realised At Derecognition of GBP 539.00 thousand for the 12-month period ending 2019-01-31, per its 20-F filed 2019-03-29.
Discontinued › Income Statement › Other Income
ifrs-full:AmountPresentedInOtherComprehensiveIncomeRealisedAtDerecognition · last filed 2019-03-29
| Period end | Amount Presented In Other Comprehensive Income Realised At Derecognition 12 month |
|---|---|
| 2019-01-31 | 539.00K GBP 20-F · filed 2019-03-29 |
| 2018-01-31 | 908.00K GBP 20-F · filed 2019-03-29 |
| 2017-01-31 | 0.00 GBP 20-F · filed 2019-03-29 |
| 2016-01-31 | 0.00 GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |